Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hemodynamics and Metabolic Parameters in Normothermic Kidney Preservation Are Linked With Donor Factors, Perfusate Cells, and Cytokines. | Front Med (Lausanne) | 2021 | 35083252 | PubTator, text mining | PubMed |
| Urinary neutrophil gelatinase-associated lipocalin level as a biomarker of acute kidney injury following extracorporeal shock wave lithotripsy. | Cent European J Urol | 2021 | 35083080 | PubTator, text mining | PubMed |
| Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models. | Antioxidants (Basel) | 2021 | 35052590 | PubTator, text mining | PubMed |
| Cancer metabolism and intervention therapy. | Mol Biomed | 2021 | 35006438 | PubTator, text mining | PubMed |
| Analysis of Risk Factors for Perioperative Acute Kidney Injury and Management Strategies. | Front Med (Lausanne) | 2021 | 35004722 | PubTator, text mining | PubMed |
| Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease. | Front Pharmacol | 2021 | 35002729 | PubTator, text mining | PubMed |
| Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment. | Front Cardiovasc Med | 2021 | 34970606 | PubTator, text mining | PubMed |
| Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials. | Cureus | 2021 | 34963839 | PubTator, text mining | PubMed |
| The Effects of Butyrate on Induced Metabolic-Associated Fatty Liver Disease in Precision-Cut Liver Slices. | Nutrients | 2021 | 34959755 | PubTator, text mining | PubMed |
| A Review of Prognosis Model Associated With Cardiogenic Shock After Acute Myocardial Infarction. | Front Cardiovasc Med | 2021 | 34957245 | PubTator, text mining | PubMed |
| The Involvement of TRIB3 and FABP1 and Their Potential Functions in the Dynamic Process of Gastric Cancer. | Front Mol Biosci | 2021 | 34957220 | PubTator, text mining | PubMed |
| Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise. | Int J Environ Res Public Health | 2021 | 34948944 | PubTator, text mining | PubMed |
| Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions. | Int J Mol Sci | 2021 | 34948113 | PubTator, text mining | PubMed |
| Does Artificial Intelligence Make Clinical Decision Better? A Review of Artificial Intelligence and Machine Learning in Acute Kidney Injury Prediction. | Healthcare (Basel) | 2021 | 34946388 | PubTator, text mining | PubMed |
| Complicating Acute Myocardial Infarction. Current Status and Unresolved Targets for Subsequent Research. | J Clin Med | 2021 | 34945202 | PubTator, text mining | PubMed |
| Urinary Biomarkers of Mycotoxin Induced Nephrotoxicity-Current Status and Expected Future Trends. | Toxins (Basel) | 2021 | 34941686 | PubTator, text mining | PubMed |
| Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion. | Gastroenterol Rep (Oxf) | 2021 | 34925848 | PubTator, text mining | PubMed |
| The Role of RIPC in Preventing Organ Damage, Inflammation, and Oxidative Stress during Lower Limb DSA: A Randomised Controlled Trial. | Oxid Med Cell Longev | 2021 | 34925697 | PubTator, text mining | PubMed |
| An Integration of Network Pharmacology and Experimental Verification to Investigate the Mechanism of Guizhi to Treat Nephrotic Syndrome. | Front Pharmacol | 2021 | 34925015 | PubTator, text mining | PubMed |
| Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver. | J Hepatocell Carcinoma | 2021 | 34917552 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=52